The 3 best performing ASX shares of the week of 5 December 2022

Marc Kennis Marc Kennis, December 12, 2022

The 3 best performing ASX shares in the week of 5 December 2022

 

The 3 best performing ASX shares of the week starting 5 December 2022 were Tombador Iron (ASX:TI1), up 38.1%, Macarthur Minerals (ASX:MIO), up 25%, and Cardiex (ASX:CDX), up 22.2%.

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

 

1. Tombador Iron (ASX:TI1)

Industry: Resources

Our top 3 best performing ASX shares kicks off with Tombador Iron (ASX:TI1), which owns 100% of the fully permitted Tombador Iron Ore mine located in Bahia State Brazil. Tombador commenced production of premium-grade lump and fines hematite iron ore in May 2021 from a low-capex open-pit mining operation.

Market Cap: $62m

12 month high / low: $0.019 – $0.055

 

Tombador Iron

 

 

2. Macarthur Minerals (ASX:MIO)

Industry: Resources

Macarthur Minerals (ASX:MIO) is an iron ore development, gold and lithium exploration company that is focused on bringing to production its 100% owned Western Australia iron ore projects.

Market Cap: $33m

12 month high / low: $0.125 – $0.64

 

Macarthur Minerals

 

 

3. Cardiex (ASX:CDX)

Industry: Healthcare

Cardiex Limited (ASX:CDX) rounds out our top 3 best performing ASX shares this week. CDX is an ASX listed public company with operations in medical technology, wearable devices and telehealth, providing digital and device-based solutions for large-scale population health disorders with significant market scale. Its current focus is cardiovascular disease (CVD) and heart health.

Market Cap: $49m

12 month high / low: $0.25 – $0.72

 

Cardiex

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

ASX stocks fighting diabetes

Here are 3 ASX stocks fighting diabetes and the opportunity ahead of them

There aren’t many ASX stocks fighting diabetes, but the few that are have a big market opportunity ahead of them. And…

predictive discovery

Predictive Discovery (ASX:PDI): It’s got a 4.2Moz gold deposit, but should you buy now?

Few stocks have ever gained more than 700% in a day, but Predictive Discovery (ASX:PDI) did just that back in…

PEP11

PEP11 has been cancelled, and that’s bad news for these stocks

PEP11 (Petroleum Exploration Permit 11) has officially been cancelled by the federal government. Federal Industry and Science Minister Ed Husic…